A substantial body of research has indicated that CD155 participates in the immune evasion mechanisms of a wide range of cancers, primarily by modulating the activation and infiltration of CD8+T cells within the tumor microenvironment [22, 23]. This evidence concerns the gene CD8A and cancer.